<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel>
            <title>Archives of Vascular Medicine </title>
            <link>https://www.vascularmedjournal.com/feed</link>
            <description>Introduction
Vascular Surgery and Medicine focuses on diagnosis, treatment and comprehensive care of patients with diseases of the arterial, venous and lymphatic systems. The specialty evolved from general and cardiac surgery as well as minimally invasive techniques pioneered by interventional radiology.
Archives of Vascular Medicine is a high&#45;impact journal concocting and publishing painstakingly peer&#45;reviewed manuscripts on the discoveries, developments and interventions in the field of vascular surgery and medicine.
The manuscripts published in Archives of Vascular Medicine are uniquely poised to provide knowledge and contribute insights to the scientific foundation of the vascular surgery specialty.
Reasons for Publishing
The credibility and standing of vascular surgery in the medical and surgical community is directly proportional to the quality and number of research contributions by vascular surgeons. A paradigm shift has occurred in recent decades in the treatment of vascular diseases. Diseases once treated exclusively by traditional open surgery are now increasingly being approached via percutaneous and hybrid techniques.
Therefore, Archives of Vascular Medicine initiated publishing manuscripts that can bring forth different provocative issues to enhance patient care, training and research in the various dimensions of vascular surgery and allied medicines.
Archives of Vascular Medicine also seek to publish stuffs on management of risk factors that should be optimized to control the progression of vascular disease conditions.</description>

                    <item>
            <type>Case Report</type>
            <title>Intravenous Leiomyomatosis of the Uterus with Intracardiac Extension</title>
            <author>Tomas Reyes-del Castillo,Minerva I Hernandez-Rejon,Jose L Ruiz-Pier,Mario Peñaloza-Guadarrama,Carlos E Merinos-Avila,Cristina Juarez-Cabrera,Pedro A del Valle-Maldonado,Sofia Ley-Tapia,Valentín Gonzalez-Flores</author>
            <pubDate>2025-07-22 17:28:17</pubDate>
            <description>Background: Intravascular Leiomyomatosis (IVL) is an often misdiagnosed rare benign mesenchymal tumor characterized by the presence of vascular extension and invasion of smooth muscle cells in a serpiginous-like pattern, first originating in uterine smooth muscle cells. Its growth pattern can involve both ovarian veins, the inferior vena cava, and even reach the right atrium/ventricle in 45% of the cases. The incidence has been reported to be 0.25 to 0.40% of patients with uterine leiomyoma, with about 300 cases reported in the literature. Also, since the tumor is hormone-dependent, most affected individuals are premenopausal women in middle age. Optimal treatment for IVL is complete surgical removal with hysterectomy and oophorectomy, independent of stage. The most frequent perioperative complications are hemorrhage due to tumoral hypervascularization, embolism, and the usual laparotomy complications. We present the case of a 51-year-old female with IVL stage 3 with complete single-stage surgical resolution.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1021.pdf</link>
        </item> 
                    <item>
            <type>Short Review</type>
            <title>Estimation of Radiation Dose to Blood Vessels and Components from Medical Imaging Procedures: Current Status</title>
            <author>Khalid M Aloufi</author>
            <pubDate>2025-05-08 15:03:38</pubDate>
            <description>Aim: This study aims to determine the current status for estimation of radiation dose to blood vessels and components from medical imaging procedures.Methodology: A database search on internet via PubMed and Google Scholar was performed to find published papers in estimation of radiation dose to blood vessels and components from medical imaging procedures.&amp;nbsp;Results: Few published papers were found; namely two published papers. Radiation dose to blood vessels and components were assumed to be included in total radiation dose estimation for organ or tissue, without considering different in radiosensitivity.&amp;nbsp;Conclusion: It seems that effect of radiation on blood vessels and components is underestimated, in ICRP 60 and 103 recommendations reports.&amp;nbsp;Recommendation: It is recommended to conduct more studies to estimate radiation dose for blood vessels and components from medical imaging procedures and revise the value of tissue weighting factor for bone marrow.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1020.pdf</link>
        </item> 
                    <item>
            <type>Case Report</type>
            <title>A Case Report on Paradoxical Emboli</title>
            <author>You Li* and Jason Wheeler</author>
            <pubDate>2024-10-17 16:11:39</pubDate>
            <description>Venous Thromboembolism (VTE) is a major public health concern, affecting approximately 900,000 people annually in the United States. In rare cases, a Patent Foramen Ovale (PFO) may allow a venous thrombus to cross into the arterial circulation, causing a paradoxical embolism. This case report presents a 46-year-old male who developed left renal artery stenosis after a paradoxical embolism, likely triggered by a prolonged flight and binge alcohol consumption. The patient was found to have a moderate-sized PFO and renal infarction, confirmed by imaging studies. Despite initial anticoagulation therapy and a planned stenting procedure, intraoperative findings revealed only mild stenosis, leading to cancellation of the stent placement. The patient ultimately underwent PFO closure with an Amplatzer Talisman device. This case underscores the diagnostic challenges in managing paradoxical embolism and the need for individualized treatment, particularly concerning anticoagulation duration, the decision for PFO closure, and post-procedural antithrombotic therapy. Further research is required to establish optimal management strategies for cryptogenic embolic events.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1019.pdf</link>
        </item> 
                    <item>
            <type>Case Series</type>
            <title>Adalimumab in the Treatment of Complex Sarcoidosis&#45;related Inflammatory Eye Disease: A Case Series</title>
            <author>Mina Al-Awqati, Supritha Prasad*, Valeria Esparza, Jacqueline Jansz, Wuily Carpio, Christian Ascoli, Huan Chang, Pooja Bhat, Ann-Marie Lobo-Chan, Nadera Sweiss</author>
            <pubDate>2024-05-21 12:39:20</pubDate>
            <description>Background: Sarcoidosis is a systemic granulomatous inflammatory disease that is associated with inflammatory eye manifestations such as uveitis, cystoid macular edema, and retinal vasculitis. Although Corticosteroids (CS) have traditionally been the mainstay of treatment, there is a clinical need and growing interest in exploring alternative therapeutic options for patients who are refractory to or intolerant of CS or require long-term steroid-sparing agents.&amp;nbsp;Purpose: This case series aims to describe the effectiveness of adalimumab, an anti-tumor necrosis factor (TNF)-&amp;alpha; monoclonal antibody, in the management of complex sarcoidosis-related inflammatory eye disease via reduction in CS dosage and ocular exam findings before and after initiation of adalimumab therapy.Method: A retrospective chart review of patients between 2010 and 2023 seen at our academic center&amp;rsquo;s rheumatology and eye clinics was conducted, with 5 patients meeting the inclusion criteria.&amp;nbsp;Results: Most patients were able to lower, discontinue, or remain off oral CS, while all 5 patients demonstrated a reduction in uveitis activity, Cystoid Macular Edema (CME), and/or retinal vasculitis.&amp;nbsp;Conclusion: These findings suggest a potential role for adalimumab as an effective and safe therapeutic option in the management of complex sarcoidosis-related inflammatory eye disease.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1018.pdf</link>
        </item> 
                    <item>
            <type>Mini Review</type>
            <title>Heart failure with preserved ejection fraction: A mini review</title>
            <author>Nathan Buila,Jean-René M’Buyamba-Kabangu</author>
            <pubDate>2022-07-22 12:49:41</pubDate>
            <description>Over the past 20 years, there has been a surge of clinical investigations and useful trials on heart failure (HF) with preserved ejection fraction (HFpEF). HFpEF represents the largest phenotype of HF, a public health concern for its link with high mortality and rates of morbidity.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1016.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>The effect of frequency of sexual intercourse on coronary artery disease</title>
            <author>Mehdi Karasu,Özkan Karaca,Mehmet Ali Kobat,Tarık Kıvrak,Mehmet İkbal İpek</author>
            <pubDate>2022-06-07 10:23:34</pubDate>
            <description>Background: Doubts about the safety of sexual activity are common among cardiac patients and physicians alike, and are often neglected during routine checkups or on discharge from the hospital following a cardiac event or invasive procedure. Although it varies from society to society, it is considered taboo by most patients, so it is reluctant to ask the doctor about sexual activity. Doctors, on the other hand, remain silent due to the lack of clear information about the effect of sexual activity on coronary artery diseases or the presence of doubts. It is ultimately set aside by professionals and their patients. The patient does not ask and the doctor does not answer. This study, it was aimed to investigate the effect of the frequency of sexual intercourse on coronary artery disease.&amp;nbsp;Methods: After applying the exclusion criteria, the remaining 180 patients were included in the study. A self-administered survey was applied to the patients before coronary angiography and patients were assessed according to the presence of additional diseases, their demographic characteristics, and the frequency of sexual intercourse. Two experienced physicians evaluated the angiographic results. Firstly Patients were grouped as 90 patients with normal coronary anatomy and 90 patients with coronary artery disease. After this, Coronary artery disease severity was evaluated according to syntax score.&amp;nbsp;Results: The mean age of the patients was 58 &amp;plusmn; 12.5 years. The distribution of age is not reasonable. According to gender, the female/male ratio the proportion of men was higher in patients with coronary artery disease. İncidence of normal coronary anatomy increased as the frequency of sexual intercourse increased. P - value was 0.037 and the result was statistically significant. The frequency of sexual intercourse was found to be 4.2/per month. The relationship between the Syntax score and frequency of sexual intercourse was not statistically significant&amp;nbsp;(p &amp;gt; 0.05).Conclusion: As a result of the study, it was seen that patients with more frequent sexual intercourse had more normal coronary artery anatomy, and those with coronary artery disease had single coronary artery disease than multiple vascular disorders. it was concluded that the incidence of coronary artery disease and coronary artery disease severity decreased as the frequency of sexual intercourse increased. Sexual intercourse might be a preventive factor in the development of coronary artery disease.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1015.pdf</link>
        </item> 
                    <item>
            <type>Mini Review</type>
            <title>Bleeding complications at the access sites during catheter directed thrombolysis for acute limb ischaemia: Mini review</title>
            <author>Elias Noory,Tanja Böhme,Ulrich Beschorner,Thomas Zeller</author>
            <pubDate>2021-03-03 00:00:00</pubDate>
            <description>Acute and subacute ischemia of the lower limbs represents a major emergency with a high in-hospital mortality, complication, and leg amputation rates.
Treatment options for acute limb ischemia include systemic anticoagulation, followed by various catheter based options including infusion of fibrinolytic agents (pharmacological thrombolysis), pharmacomechanical thrombolysis, catheter-mediated thrombus aspiration, mechanical thrombectomy, and any combination of the above or open surgical intervention (thromboembolectomy or surgical bypass).
Minor and major bleeding complication during catheter directed thrombolysis (CDT) especially at access site are frequent. Bleeding complications require often an interruption or termination of CDT affecting clinical outcome of the patients. Recently we examined a new access site bleeding protection device during CDT.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1014.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Clinical characteristics in STEMI&#45;like aortic dissection versus STEMI&#45;like pulmonary embolism</title>
            <author>Oscar MP Jolobe</author>
            <pubDate>2020-07-31 00:00:00</pubDate>
            <description>Dissecting aortic aneurysm with ST segment elevation, and pulmonary embolism with ST segment elevation are two of a number of clinical entities which can simulate ST segment elevation myocardial infarction.
Objective: The purpose of this review is to analyse clinical features in anecdotal reports of 138 dissecting aortic aneurysm patients with STEMI-like presentation, and 102 pulmonary embolism patients with STEMI-like presentation in order to generate insights which might help to optimise triage of patients with STEMI-like clinical presentation.
Methods: Reports were culled from a literature search covering the period January 2000 to March 2020 using Googlescholar, Pubmed, EMBASE and MEDLINE. Reports were included only if there was a specification of the location of ST segment elevation and an account of the clinical signs and symptoms. Search terms were &amp;ldquo;ST segment elevation&amp;rdquo;,&amp;rdquo;aortic dissection&amp;rdquo;, &amp;ldquo;pulmonary embolism&amp;rdquo;, &amp;ldquo;myocardial infarction&amp;rdquo;, and &amp;ldquo;paradoxical embolism&amp;rdquo;. Fisher&amp;rsquo;s exact test was utilised for two-sided comparison of proportions. Proportion was calculated for each group as the number of patients with that parameter relative to the total number of patients assessed for that parameter.
Findings: There were 138 patients with aortic dissection, 91 of whom were either fast-tracked to coronary angiography (81 patients) or fast-tracked to thrombolytic treatment (10 patients). There were 47 patients managed with neither of those strategies. There were 102 patients with pulmonary embolism, 71 of whom were fast tracked to coronary angiography, and 31 who did not receive that evaluation. Compared with their dissecting aortic aneurysm counterparts, those dissecting aortic aneurysm patients initially managed by percutaneous coronary intervention or by thrombolysis were significantly (p = 0.0003) more likely to have presented with chest pain, and significantly (p = 0.018) less likely to have presented with breathlessness. The preferential fast-tracking to coronary angiography prevailed in spite of comparable prevalence of back pain in fast tracked and in non-fast tracked subjects. Use of transthoracic echocardiography was also comparable in the two subgroups of dissecting aortic aneurysm patients. Pulmonary embolism patients fast tracked to percutaneous coronary intervention were significantly (p = 0.0008) more likely to have presented with chest pain than their pulmonary embolism counterparts who were not fast-tracked. The prevalence of paradoxical embolism was also significantly (p = 0.0016) higher in fast-tracked patients than in counterparts not fast-tracked. Cardiac arrest was significantly (p = 0.0177) less prevalent in fast-tracked pulmonary embolism patients than in pulmonary embolism patients who were not fast-tracked. Preferential fast-tracking to coronary angiography prevailed in spite of the fact that prevalence of documented deep vein thrombosis was comparable in fast-tracked subjects and in subjects not fast-tracked. The prevalence of use of transthoracic echocardiography was also similar in fast-tracked pulmonary embolism patients vs counterparts not fast tracked. Overall, however, transthoracic echocardiography had been utilised significantly (p = 0.007) less frequently in dissecting aneurysm patients than in pulmonary embolism patients.
Conclusion: Given the high prevalence of STEMI-like presentation in aortic dissection there is a need for greater use of point-of-care transthoracic echocardiography to mitigate risk of inappropriate percutaneous coronary intervention(which might delay implementation of aortic repair surgery) and inappropriate thrombolysis(which might precipitate hemorrhagic cardiac tamponade) (75) during triage of patients presenting with ST segment elevation simulating ST segment elevation myocardial infarction (STEMI). Furthermore, during triage of patients with STEMI-like clinical presentation, the combined use of point-of -care echocardiography and evaluation for deep vein thrombosis will facilitate the differentiation between acute myocardial infarction, STEMI-like aortic dissection, and STEMI-like pulmonary embolism. Among STEMI-like patients in whom DAA has been ruled out by point of care TTE, fast tracking to PCI might generate an opportunity to identify and treat paradoxical coronary artery embolism by thrombectomy. Thereby mitigating the mortality risk associated with coronary occlusion. Concurrent awareness of PE as the underlying cause of paradoxical embolism also generates an opportunity to relieve the clot burden in the pulmonary circulation, either by pulmonary embolectomy or by thrombolysis. Above all, frontline clinicians should have a greater awareness of the syndrome of STEMI-like presentation of aortic dissection and STEMI-like pulmonary embolism so as to mitigate the risk of inappropriate thrombolysis and inappropriate percutaneous coronary angiography which seems to prevail even in the presence of red flags such as back pain (for aortic dissection) and deep vein thrombosis(for pulmonary embolism).&amp;nbsp;</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1013.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Atypical manifestations of pulmonary embolism</title>
            <author>Oscar MP Jolobe</author>
            <pubDate>2020-04-16 00:00:00</pubDate>
            <description>Pulmonary embolism (PE) is an age-related disorder which is potentially fatal, but frequently misdiagnosed. However, the true prevalence of pulmonary embolism is unknown. Inaccurate estimates of PE prevalence might, in part, be attributable to underrecognition of atypical presentations of this disorder. If true prevalence is unknown, the positive predictive values of both typical and atypical symptoms and signs of PE will be unreliable. The negative predictive value of those parameters will, likewise, be unreliable. The aim of this review is to make clinicians more aware of atypical manifestations of PE, thereby increasing the likelihood of correct diagnosis and, hence, ascertainment of the true prevalence of PE. The range of atypical manifestations was explored by a literature search, using MEDLINE from 1946 to February 2019, and EMBASE, from 1947 to February 2019, and Pubmed, from February 2014 to February 2019, using the search terms atypical, uncommon, unusual, pulmonary embolism, lung embolism, pulmonary thromboembolism.
This search revealed atypical presenting features such as non pleuritic retrosternal pain, abdominal pain, atypical breathing patterns, pulmonary oedema, Dressler&amp;rsquo;s syndrome, atypical radiographic manifestations, atypical electrocardiographic features, manifestations associated with oxygen saturation of 95% or more, coexistence of acute myocardial infarction and pulmonary embolism, coexistence of thoracic aortic dissection and pulmonary embolism, neurological manifestations other than stroke, paradoxical embolism, acute venous thrombosis of atypical location, and pulmonary embolism with normal D-dimer levels.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1012.pdf</link>
        </item> 
                    <item>
            <type>Review Article</type>
            <title>Foam Sclerotherapy versus surgery in treatment of chronic venous disease</title>
            <author>Fatih Islamoglu</author>
            <pubDate>2020-04-13 00:00:00</pubDate>
            <description>Although the classical surgical treatment methods of chronic venous insufficiency are successful to relieve perfectly the cause (reflux) and result (varicose veins), the new ablation techniques such as endogenous laser ablation therapy (EVLT), radiofrequency (RF) and foam ablation come into currency more and more with their advantage of being performed with only local anesthesia. However, these techniques, still have the potential for residual saphenofemoral reflux due to incomplete ablation of all side branches of the saphenofemoral junction. As an alternative technique ligation + foam sclerotherapy is not only comfortable like EVLT or RF but also safe and effective as much as classic stripping.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1011.pdf</link>
        </item> 
                    <item>
            <type>Opinion</type>
            <title>PR and QT intervals short on the same electrocardiogram</title>
            <author>Francisco R Breijo-Márquez</author>
            <pubDate>2020-04-07 00:00:00</pubDate>
            <description>In 2007, Professor Breijo-M&amp;aacute;rquez described an electrocardiographic pattern, consisting of the presence of a short PR interval (or PQ) together with a short QT interval in the same individual. It was published with the headline &amp;ldquo;Decrease in cardiac electrical systole&amp;rdquo; in International Journal of Cardiology (IJC) [1].</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1010.pdf</link>
        </item> 
                    <item>
            <type>Case Report</type>
            <title>A fatal portal vein thrombosis: A case report</title>
            <author>M Kechida,W Ben Yahia,W Mnari</author>
            <pubDate>2019-07-27 00:00:00</pubDate>
            <description>Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematologic condition which could be revealed by deep venous thrombosis. It could be fatal unless correctly treated.
Case report: We report here the case of a 28 year-old male with no medical history who was admitted to the emergency room for severe abdominal pain. Computerized Tomography angiography (CT) scan revealed portal vein thrombosis. Laboratory findings showed pancytopenia with severe regenerative normocytic anemia resulting in PNH. Because of the lack of Eculizumab, treatment was first based on curative anticoagulation until bone marrow transplant, with no success.
Conclusion: PNH remains a severe disease with bad prognosis unless treated with Eculizumab.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1009.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Transcatheter embolization of congenital vascular malformations, single center experience</title>
            <author>Mohammed Habib,Majed Alshounat</author>
            <pubDate>2019-06-07 00:00:00</pubDate>
            <description>Background: Congenital Vascular malformation relatively rare and extremely varied clinical presentations. The purpose of our study was to present our initial experience of embolization in a series of 26 patients with congenital vascular malformation to assess retrospectively the results and the complications of ethanol and coils embolization treatment of these patients.
Methods: Retrospective trial, the study group consisted of 26 patients with congenital vascular malformations. Transcatheter arterial embolization by ethanol or coils were performed, Therapeutic outcomes were established by evaluating the clinical outcome of symptoms and signs, as well as the degree of devascularization at follow-up angiography.
Results: Between November 2014 and March 2018, 26 consecutive patients (3 male, 23 female) at Alshifa Hospital - Cardiac Catheterization Center with congenital vascular malformations in the body and extremities underwent staged ethanol or coils embolization. The mean age of the patients was 25 years (age range, 6&amp;ndash; 59 years). Ethanol embolization was administrated in 16 patients, coil embolization in 9 patients and graft stent in one patient. The side effect such as pain, pulsation, and bruit in most of the patients were obtained. The reduction of redness, swelling, and warmth was achieved in all of the patients, According to the angiographic findings, congenital vascular malformation were devascularized 100% in 12 patients, 50% to 99% in 11 patients, less than 50% in 3 patients. The most common complications were reversible skin necrosis.
Conclusion: Transcatheter embolization by ethanol or coils has proved efficacious and safe in the treatment of congenital vascular malformation of the body and extremities but with acceptable risk of complications</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1008.pdf</link>
        </item> 
                    <item>
            <type>Opinion</type>
            <title>Navigation in the land of Scarcity</title>
            <author>Awad Magbri,Mariam El-Magbri</author>
            <pubDate>2018-12-28 00:00:00</pubDate>
            <description>Delivering health care is a complex task that marginalized a portion of the population intentionally or unintentionally. Discrepancy in health care providing to the intended patients is sometimes accompanied by unintended collateral damage to the bystanders who desperately needing our help and assistance.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1007.pdf</link>
        </item> 
                    <item>
            <type>Mini Review</type>
            <title>Severe aorto&#45;iliac occlusive disease: Options beyond standard aorto&#45;bifemoral bypass</title>
            <author>Konstantinos Filis,Constantinos Zarmakoupis,Fragiska Sigala,George Galyfos </author>
            <pubDate>2018-12-27 00:00:00</pubDate>
            <description>According to recent guidelines, endovascular angioplasty is the standard treatment for TASC A and B primary aorto-iliac occlusive (AIOD) disease, and the first-line approach for TASC C lesions [1,2]. Extended TASC D occlusive disease is usually treated by open surgery yielding excellent patency rates at a cost of a higher mortality (2%-4%) and a severe morbidity (up to 10%) [3]. However, several studies have reported promising results after endovascular treatment of extensive AIOD and full reconstruction of the aortic bifurcation [4,5]. In a recent meta-analysis, Jongkind et al., concluded that endovascular treatment of extensive AIOD can be performed successfully by experienced interventionists in selected patients [6]. Although primary patency rates seem to be lower than those reported for surgical revascularization, reinterventions can often be performed percutaneously yielding a secondary patency comparable to surgical repair.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1006.pdf</link>
        </item> 
                    <item>
            <type>Review Article</type>
            <title>Anesthetic considerations for endovascular repair of ruptured abdominal aortic aneurysms</title>
            <author>KH Kevin Luk,Koichiro Nandate</author>
            <pubDate>2018-09-11 00:00:00</pubDate>
            <description>Ruptured abdominal aortic aneurysm (rAAA) carries high morbidity and mortality. Advances in endovascular techniques in the last two decades allow for minimally invasive approach for repair of these aneurysms. A succinct but comprehensive pre-operative is essential for delivery of a safe anesthetic for the patient with rAAA. Placement of proximal occlusion balloon in the descending aorta using the rapid control technique can be life-saving. Endovascular aortic repair (EVAR) can be performed under monitored anesthesia care using local anesthetic and IV sedation, and with fewer invasive lines. However, rapid conversion to general endotracheal anesthesia should be expected. Anesthesiologists should be familiar with the hemodynamic management of rAAA and be ready to provide resuscitation to correct for anemia, coagulopathy, and acidemia. In addition, the anesthesiologist should be aware of the common complications related to EVAR, including abdominal compartment syndrome, distal ischemia, and local vessel injury.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1005.pdf</link>
        </item> 
                    <item>
            <type>Case Report</type>
            <title>Cystic adventitial disease of the external iliac artery with disabling claudication: A case report and short review</title>
            <author>Nalaka Gunawansa</author>
            <pubDate>2018-07-03 00:00:00</pubDate>
            <description>Chronic occlusive arterial disease of the periphery is primarily caused by atherosclerotic disease. In young patients with no identifi able risk factors for atherosclerosis, who present with symptoms of claudication or critical ischemia, other rare causes need to be suspected. Cystic adventitial disease is one such condition affecting young healthy patients. Although it has been reported most commonly in relation to the popliteal artery, other sites including the iliac artery can also get affected. Isolated short segment stenosis or occlusion can lead to signifi cant disabling symptoms restricted to one side. Imaging studies show pristine arterial anatomy with no evidence of systemic atherosclerotic disease and an isolated area of luminal stenosis. Defi nitive treatment involves open surgical excision with interposition grafting for optimal long-term results. We report a case of cystic adventitial disease affecting the external iliac artery in an otherwise healthy young man.&amp;nbsp;</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1004.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Management of Popliteal Artery aneurysms: Experience in our center</title>
            <author>Michiels Thirsa,Vleeschauwer De Philippe</author>
            <pubDate>2018-01-25 00:00:00</pubDate>
            <description>Background: Popliteal artery aneurysms (PAAs) are rare, but the diagnosis should not be missed because of the limb and life threatening complications. The purpose of this study was to reach a consensus about the management of PAA based on our own experience and the available literature.
Materials and Methods: This is a retrospective analysis of all patients who underwent an open surgical PAA repair at our institution from January 2015 to December 2016. Demographic data, risk factors, clinical presentation, aneurysm characteristics, type of repair and results were reviewed. Results include patency and major complications.
Results: Seven patients underwent an open surgical PAA repair (six men). Median age was 72 years. A posterior approach (PA) was chosen four times and a medial approach (MA) was chosen three times. We performed six resections with interposition of a graft and only one ligation with a bypass. Five patients recovered well, did not develop any complication and did not need a second intervention to guarantee patency. These patients underwent a resection of the aneurysm and interposition of a graft (four via a PA and one via a MA). One patient treated by resection and interposition of a Dacron graft via a MA underwent an above-the-knee amputation at postoperative day 14. This patient had a preoperatively dysfunctional leg since several months with no patent outflow vessels. Our patient treated by ligation and bypass via a MA, developed an acute ischemia four months postoperatively because of an extreme flexion of the knee during several hours while watching TV. After unsuccessful trombolysis, he underwent a femorotibial bypass and a partial forefoot amputation. No long-term results are yet available.
Conclusions: In our opinion, open surgical repair of PAAs by resection of the aneurysm and interposition of a venous graft has the best results. Depending on the relation to the knee joint and thus the accessibility of the aneurysm, a posterior approach is preferred. We are not convinced of endovascular techniques in the treatment of popliteal artery aneurysms</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1003.pdf</link>
        </item> 
                    <item>
            <type>Case Report</type>
            <title>Hepato&#45;Pulmonary syndrome and Porto&#45;Pulmonary Hypertension: Rare combination cause of Hypoxemia in patient with end&#45;stage renal failure on Hemodialysis and hepatitis C Induced Decompensated Cirrhosis</title>
            <author>Awad Magbri,Mariam El-Magbri,Eussera El-Magbri</author>
            <pubDate>2017-12-18 00:00:00</pubDate>
            <description>The case is that of 83 year-old African American man with hypertension, hepatitis C induced decompensated cirrhosis with ascites, end-stage renal disease (ESRD) on hemodialysis, fluid overload with peripheral edema and chronic hypotension. The patient was referred to the dialysis access center of Pittsburgh, PA for evaluation of his prolonged bleeding from the left upper arm brachial-basilic arterial-venous fistula (BBAVF).</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1002.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>The Impact of a Single Apheretic Procedure on Endothelial Function Assessed by Peripheral Arterial Tonometry and Endothelial Progenitor Cells</title>
            <author>Gabriele Cioni,Francesca Cesari,Rossella Marcucci,Anna Maria Gori,Lucia Mannini,Agatina Alessandrello Liotta,Elena Sticchi,Ilaria Romagnuolo,Rosanna Abbate,Giovanna D’Alessandri</author>
            <pubDate>2017-02-22 00:00:00</pubDate>
            <description>Introduction: Endothelial progenitor cells (EPC) are involved in vascular repair and proliferation, contributing to the long-term outcomes of apheretic treatment. Aim of this study was to investigate the relationships between endothelial function, assessed by levels of bone marrow-derived progenitor cells and endothelial response to hyperaemia, and clinical and biohumoral parameters in high vascular risk patients before, immediately after, 24-hours and 72 hours after a single lipid apheresis procedure.
Material and Methods: We evaluated lipid profile, endothelial function and endothelial progenitor cells before (T0), immediately after (T1), 24h after (T2) and 72h after (T3) a lipoprotein apheresis procedure, in 8 consecutive patients [Sex: 62.5% M; Age; 63.29(12), mean, (range) years] with a personal history of acute coronary syndrome, symptomatic peripheral arterial disease and elevated plasma levels of lipoprotein (a) [Lp(a)]. Patients were on regularly weekly or biweekly lipoprotein apheresis, and they were treated with the FDA-approved Heparin-induced Extracorporeal LDL Precipitation (H.E.L.P.) (Plasmat Futura, B.Braun, Melsungen, Germany) technique. PAT values were expressed as the natural logarithm (Ln-RHI, normal values&amp;ge;0.4) of the reactive hyperaemia index (RHI), which is the parameter automatically calculated by the device.
Results: We found a reduction in the natural logarithm of reactive hyperaemia index (Ln-RHI), assessed immediately after the procedure (0.57&amp;plusmn;0.21 vs 0.72&amp;plusmn; 0.29); difference between T2 and T0 was statistically significant (0.43&amp;plusmn;0.24 vs 0.72&amp;plusmn;0.29; p=0.006). Reduction in Ln-RHI values was documented in all patients, two subjects showing a Ln-RHI&amp;lt;0.4 at T1, and four at T2. At T3, PAT values were increased significantly (0.91&amp;plusmn;0.18) in comparison to T1 and T2, showing a median value higher than at T0. Cd34+/Kdr+ and Cd133+/Kdr+ showed a minimum increase in median values at T1, and a higher increase at T2, in comparison to baseline. Differences in Cd34+/133+/Kdr+ values at different times were not statistically significant. A significant reduction in circulating endothelial cells (CEC) count at T2 in comparison to T0 was found (12.00&amp;plusmn;8.85 vs 23.86&amp;plusmn;12.39; p=0.024).
Discussion: At 24h and 72h after procedures, we found an improvement in endothelial function, expressed by an increase in PAT values and EPC levels, and by a reduction in CEC.</description>
            <link>https://www.vascularmedjournal.com/articles/avm-aid1001.pdf</link>
        </item> 
                        <!-- end item Block -->
    </channel>
</rss>